The global antinuclear antibody test market is registering a considerably high-paced growth. The increasing prevalence of autoimmune disorders, such as diabetes and thyroid, is boosting this market significantly. Antinuclear antibody testing systems, reagents and assay kits, and software and services are the main products available in the global antinuclear antibody test market. Among these, the demand for reagents and assay kits is relatively higher and this scenario is likely to remain so over the next few years. The increased application of reagents and assay kits in clinics and research institutes is likely to drive the growth in this product segment.
In terms of application, antinuclear antibody test finds extensive usage in the diagnosis of systemic lupus erythematous, scleroderma, rheumatoid arthritis, and Sjogren’s syndrome. With the higher prevalence of rheumatoid arthritis, the demand for antinuclear antibody test is higher in this application segment as well. Immunofluorescence assay, enzyme-linked immunosorbent assay (ELISA), and multiplex assay are the prominent technologies used in antinuclear antibody tests. The ELISA technology is anticipated to report a stronger demand in the near future due to the ease of use.
North America to Continue its Dominance
Followed closely by Europe, North America has been leading the global antinuclear antibody test market. The regional market is anticipated to retain its dominance over the next few years. The high level of awareness among consumers and the presence of advanced healthcare infrastructure are likely to drive the North America antinuclear antibody test market in the near future. However, Asia Pacific will report a faster growth rate over the next couple of years. The high prevalence of autoimmune diseases in Asian countries, such as India and China is expected to propel this regional market.
Obtain PDF Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=17930
Alere Inc., Bio-Rad Laboratories, ZEUS Scientific, Antibodies Inc., Immuno Concepts, Erba Diagnostics, Inova Diagnostics, Euroimmun AG., and Trinity Biotech Plc. are some of the most prominent participants in the global antinuclear antibody test market.